Sidey, 1987 - Google Patents
Metabolic effects of Bordetella pertussisSidey, 1987
View PDF- Document ID
- 6646927757409970563
- Author
- Sidey F
- Publication year
External Links
Snippet
The present work confirmed that B. pertussis infection or pertussis toxin produce hypoglycaemia in mice. The hypoglycaemia was associated with hyperinsulinaemia, and both were abolished by destruction of the pancreatic β cells with alloxan. Impaired glucose …
- 241000588832 Bordetella pertussis 0 title abstract description 51
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pittman | The concept of pertussis as a toxin-mediated disease | |
| Donta et al. | Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum | |
| CN101310769B (en) | Multivalent DTP-POLID vaccines | |
| Lamanna | The Most Poisonous Poison: What do we know about the toxin of botulism? What are the problems to be solved? | |
| Bennett Jr et al. | Fever as a mechanism of resistance | |
| Kasamatsu et al. | Depletion of brain catecholamines: failure of ocular dominance shift after monocular occlusion in kittens | |
| HEYNINGEN | Cholera toxin | |
| Mencacci et al. | CD4+ T-helper-cell responses in mice with low-level Candida albicans infection | |
| Pichichero et al. | Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussisvs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18-to 24-month old children | |
| Kato | Antibody formation to trehalose-6, 6′-dimycolate (cord factor) of Mycobacterium tuberculosis | |
| JP2016516721A (en) | Toxoids, compositions and related methods | |
| Smorodintsev | Basic mechanisms of nonspecific resistance to viruses in animals and man | |
| Scott et al. | Herpesvirus hominis (virus of herpes simplex) | |
| KR100533818B1 (en) | Mycobacterium vaccae for down-regulation of the th2 activity of the immune system | |
| Steere | Current understanding of Lyme disease | |
| Sidey | Metabolic effects of Bordetella pertussis | |
| ES2341741T3 (en) | USE OF ACTYNOMYCETALS FOR THE TREATMENT OF TYPE II DIABETES. | |
| Fowler et al. | Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity | |
| Finkelstein et al. | Antitoxic immunity in experimental cholera: observations with purified antigens and the rat foot edema model | |
| O'Leary | Enteric redmouth bacterium of salmonids: a biochemical and serological comparison of selected isolates | |
| Curnen et al. | The effect of sulfapyridine upon the development of immunity to pneumococcus in rabbits | |
| Al-Mufarrej et al. | Effects of royal jelly on the humoral antibody response and blood chemistry of chickens | |
| Yamamoto et al. | Enhanced sensitisation of mice with diphtheria tetanus acellular pertussis vaccine to local swelling reaction to the booster immunisation | |
| Long et al. | Pathological and clinical effects of Eimeria tenella in partially immune chickens | |
| Dawson et al. | Immunological and Blood Products: Pharmaceutical Monographs |